These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33096242)

  • 1. Has the door closed on hydroxychloroquine for SARS-COV-2?
    Paul M
    Clin Microbiol Infect; 2021 Jan; 27(1):3-5. PubMed ID: 33096242
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection.
    Juurlink DN
    CMAJ; 2020 Apr; 192(17):E450-E453. PubMed ID: 32269021
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.
    Fiolet T; Guihur A; Rebeaud ME; Mulot M; Peiffer-Smadja N; Mahamat-Saleh Y
    Clin Microbiol Infect; 2021 Jan; 27(1):138-140. PubMed ID: 33080383
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann.
    Gautret P; Hoang VT; Colson P; Raoult D
    Int J Antimicrob Agents; 2021 Mar; 57(3):106306. PubMed ID: 33596459
    [No Abstract]   [Full Text] [Related]  

  • 5. Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment.
    Seligmann H
    Int J Antimicrob Agents; 2021 Mar; 57(3):106292. PubMed ID: 33714420
    [No Abstract]   [Full Text] [Related]  

  • 6. Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.
    Mori N; Katayama M; Nukaga S
    J Microbiol Immunol Infect; 2021 Feb; 54(1):109-112. PubMed ID: 33054978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine (HCQ): real treatment or false hope?
    El Bakkouri K
    Int J Antimicrob Agents; 2021 Jan; 57(1):106170. PubMed ID: 33408023
    [No Abstract]   [Full Text] [Related]  

  • 8. Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin?
    Li C; Cheng G
    Front Immunol; 2020; 11():1969. PubMed ID: 32849658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity.
    Hache G; Rolain JM; Gautret P; Deharo JC; Brouqui P; Raoult D; Honoré S
    Microb Drug Resist; 2021 Mar; 27(3):281-290. PubMed ID: 33729874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine + azithromycin treatment in elderly patients.
    Gautret P; Ly TDA; Raoult D
    Int J Antimicrob Agents; 2021 Apr; 57(4):106313. PubMed ID: 33716178
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis.
    Million M; Roussel Y; Gautret P; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106240. PubMed ID: 33408019
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19.
    Gautret P; Lagier JC; Honoré S; Hoang VT; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106242. PubMed ID: 33408033
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited.
    Gautret P; Lagier JC; Honoré S; Hoang VT; Colson P; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106243. PubMed ID: 33408014
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection.
    Voisin O; Lorc'h EL; Mahé A; Azria P; Borie MF; Hubert S; Ménage E; Guillerm JC; Mourad JJ
    Mayo Clin Proc; 2020 Aug; 95(8):1696-1700. PubMed ID: 32753141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
    Million M; Lagier JC; Gautret P; Colson P; Fournier PE; Amrane S; Hocquart M; Mailhe M; Esteves-Vieira V; Doudier B; Aubry C; Correard F; Giraud-Gatineau A; Roussel Y; Berenger C; Cassir N; Seng P; Zandotti C; Dhiver C; Ravaux I; Tomei C; Eldin C; Tissot-Dupont H; Honoré S; Stein A; Jacquier A; Deharo JC; Chabrière E; Levasseur A; Fenollar F; Rolain JM; Obadia Y; Brouqui P; Drancourt M; La Scola B; Parola P; Raoult D
    Travel Med Infect Dis; 2020; 35():101738. PubMed ID: 32387409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19.
    Colson P; La Scola B; Lagier JC; Gautret P; Raoult D
    Int J Antimicrob Agents; 2021 Jan; 57(1):106238. PubMed ID: 33408030
    [No Abstract]   [Full Text] [Related]  

  • 17. Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load.
    Nguyen TV
    Int J Antimicrob Agents; 2021 Jan; 57(1):106169. PubMed ID: 33408026
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential pro-arrhythmic effects of pharmacotherapy against SARS-CoV-2.
    Medeiros-Domingo A; Carrasco OF; Berni-Betancourt A
    Arch Cardiol Mex; 2020; 90(Supl):36-40. PubMed ID: 32523150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
    Furtado RHM; Berwanger O; Fonseca HA; Corrêa TD; Ferraz LR; Lapa MG; Zampieri FG; Veiga VC; Azevedo LCP; Rosa RG; Lopes RD; Avezum A; Manoel ALO; Piza FMT; Martins PA; Lisboa TC; Pereira AJ; Olivato GB; Dantas VCS; Milan EP; Gebara OCE; Amazonas RB; Oliveira MB; Soares RVP; Moia DDF; Piano LPA; Castilho K; Momesso RGRAP; Schettino GPP; Rizzo LV; Neto AS; Machado FR; Cavalcanti AB;
    Lancet; 2020 Oct; 396(10256):959-967. PubMed ID: 32896292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
    Goldman JD; Diaz G; Urba WJ
    Int J Antimicrob Agents; 2021 Jan; 57(1):106174. PubMed ID: 33408020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.